Headlam Group PLC
07 April 2004
For immediate release
Headlam Group plc - Exercise of share options
Headlam Group plc ('Headlam') announces that on 6 April 2004 Tony Brewer, Chief
Executive, and Steve Wilson, Finance Director, exercised share options over a
total of 214,000 shares granted under the Headlam Group 1996 Unapproved
Executive Share Option Scheme, the dates of grant and option prices of which are
detailed below.
Name Date of grant Number of Option price per Normal exercise period
shares share
Tony Brewer 15 May 1997 112,000 311.50 pence May 2000 to May 2004
Steve Wilson 15 May 1997 102,000 311.50 pence May 2000 to May 2004
Total 214,000
Immediately following the issue Tony Brewer and Steve Wilson sold 112,000 and
102,000 shares respectively at a price of £3.88 per share leaving their
beneficial shareholdings in Headlam unchanged, respectively at 443,874
representing 0.52% and 211,433 representing 0.25% of the issued share capital.
End
Released 7 April 2004
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.